Insider · CIK 0001914512
Eckburg Paul
Reports to the SEC for 1 company · MENLO PARK, CA
Transactions
5
Companies
1
Filings
4
CIK
0001914512
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-03-15 | ANTXAN2 Therapeutics, Inc.A Award | — |
| 2024-03-15 | ANTXAN2 Therapeutics, Inc.A Award | — |
| 2024-03-15 | ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-02-15 | ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-05-12 | ANTXAN2 Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4/AEckburg Paul0001610717-24-000196SEC(opens sec.gov)
- 4Eckburg Paul0001610717-24-000165SEC(opens sec.gov)
- 4Eckburg Paul0000899243-23-005555SEC(opens sec.gov)
- 4Eckburg Paul0000899243-22-018292SEC(opens sec.gov)
Companies
Address
C/O AN2 THERAPEUTICS, INC. 1800 EL CAMINO REAL, SUITE D
MENLO PARK, CA, 94027